E.g., 06/13/2021
E.g., 06/13/2021
Title Category Credit Event Date Price
AUA Live en español (2020) $0.00 ¡La AUA le entrega una experiencia de educación virtual mostrando lo mejor de la AUA!En junio, más de 4,000 participantes de todo el mundo asistieron a AUA Live, un evento de transmisión en vivo de dos días de duración que contó con más de 35 horas de programación educativa selecta, incluida una conferencia magistral del Dr.
Adjuvant Treatment in Bladder Cancer Podcast (2021)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, this podcast episode is designed to improve the ability of the urologist to care for patients with bladder cancer. This activity aims to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects. The AUA Expert Exchange Podcast: Adjuvant Treatment in Bladder Cancer is designed to address a very specific learning opportunity and reach the urologist in an easy, flexible way with a smaller, targeted update.
AUA Live (2020) $299.00 June 27 – 28, 2020The AUA brings you a virtual education experience featuring the best of AUA! This program will include two days of virtual programming across three different channels, providing more than 24 hours of education. Explore the program below.
Case-Based Discussion of AUA Non-Muscle Invasive Bladder Cancer Guidelines Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Improved understanding and rationale for diagnostic and therapeutic interventions for non invasive and invasive bladder cancer; heightened awareness of multidisciplinary efforts necessary for optimal care; algorithms and sources of information to provide to staff and patients.ACKNOWLEDGEMENTSSupport provided by independent educational grants from:AstellasAstraZenecaBristol-Myers SquibbGenentechMerckPfizer, Inc.Sanofi Genzyme
Chemo-ablation of Upper-Tract Urothelial Podcast (2020)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course will review management options for advanced prostate, bladder, and kidney cancer using evidence-based recommendations and guidelines. The trials and literature that helped to shape the guidelines will be included. Included will be older, more established therapies as well as newer treatments, including checkpoint inhibitors and antibody-drug conjugates. Learners will become familiar with not only the therapies and their mechanisms, but the data behind their approval as well as future directions.
Integrating Care for Oncology Patients: Establishing a Multidisciplinary Oncology Clinic with Advanced Therapeutics Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course will provide the framework to create a multidisciplinary clinic for the treatment of urologic malignancies, with representation of urologists, medical oncologists and additional specialists working together in a team-based approach. The course will focus on integration of advanced therapeutics including immune-based therapy where applicable in a multidisciplinary setting.
Management of NMIBC: Practical Solutions for Common Problems Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course will review the most recent AUA practice guidelines for non-muscle-invasive bladder cancer and detail strategies to manage common clinical predicaments involved in the management of these tumors. Specifically we will review: the AUA guidelines; risk stratification and use of cystectomy; selection of the optimal intravesical agent at the right schedule; and treatment of toxicity from intravesical therapy. Practical solutions will be presented that can be readily integrated into the office setting.
Robotic Urologic Surgery: A Technical Masterclass Webcast (2018) $689.00 Robotic Urologic Surgery: A Technical Masterclass provides a structured approach to advanced robotic surgery for conditions of the prostate, kidney, and bladder with an emphasis on radical prostatectomy and partial nephrectomy. This course will also focus on emerging technologies including genomic testing and advanced imaging. Experienced world-class faculty with more than a decade of experience with complex robotic surgery will provide you with instruction to refine your technique and achieve superior results.
Self-Assessment Study Program SASP (2019) $295.00 The SASP is the AUA’s most popular study tool for exam preparation! For over 40 years, the AUA's Self-Assessment Study Program (SASP) has been a leading educational resource for urologists-in-training and practicing urologists.
Sequencing of Agents and Combination of Treatment Options for Bladder Cancer Podcast (2020)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
The Expanding Role of Immune Checkpoint Inhibitors in MIBC and NMIBC Podcast (2020)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
The Journal of Urology® Volumes 199/200 Home Study Course (2018)
    • 24.00 AMA PRA Category 1 Credit™
    • 24.00 Non-Physician Participation
$60.00 Most Comprehensive and Affordable Self-study CME Product!Make the most of your Journal of Urology® SubscriptionDeveloped by a team of educators, academicians, and clinicians, this valuable home study activity will enhance your knowledge of urology and improve performance as well as patient care at your convenience. For just $2.50 per credit, the Home Study program is designed to provide urologists and residents affordable access to the most recent developments and techniques in urology while reading The Journal®.
The Journal of Urology® Volumes 201/202 Home Study Course (2019)
    • 24.00 AMA PRA Category 1 Credit™
    • 24.00 Non-Physician Participation
$60.00 Most Comprehensive and Affordable Self-study CME Product!Make the most of your Journal of Urology® SubscriptionDeveloped by a team of educators, academicians, and clinicians, this valuable home study activity will enhance your knowledge of urology and improve performance as well as patient care at your convenience. For just $2.50 per credit, the Home Study program is designed to provide urologists and residents affordable access to the most recent developments and techniques in urology while reading The Journal®.
Trimodality Therapy for Management of Muscle Invasive Bladder Cancer Webcast (2020)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 This course is a comprehensive review of tri-modal therapy for muscularis propria invasive urothelial carcinoma of the bladder with a multidisciplinary faculty including urology, radiation oncology, and medical oncology. We will review results from prospective randomized trials and large institutional experiences in tri-modality bladder sparing therapy. The course will focus on the Urologist’s critical role in patient selection for this approach vs.

Pages